Main > ENZYMES > Aspartase. > Escherichia coli ATCC 11303. > L-Aspartic Acid Production.

Product Japan. N

PATENT ASSIGNEE'S COUNTRY Japan
UPDATE 10.99
PATENT NUMBER This data is not available for free
PATENT GRANT DATE 05.10.99
PATENT TITLE Microorganisms immobilized on a solid support with a quaternary polyallylamine polymer

PATENT ABSTRACT Enzyme-containing cells are immobilized on a water-insoluble support with a polymer represented by the following general formula (I): ##STR1## wherein Y is a direct bond or a divalent group represented by the following formula (II) ##STR2## R.sub.1 and R.sub.2 are each independently hydrogen atoms or organic residues, X.sup.- represents an anion, and n is an integer of 100 to 5000. The support may be in granular form such as granules of ion exchange resins or inorganic carriers, or in sheet form such as ion exchange films or alumina or silica sheets. Immobilization may be carried out by mixing cells with water and a quaternary salt of polyallylamine as the polymer, and sprinkling the resultant mixture onto the solid support and drying. L-aspartic acid or fumaric acid can be produced by contacting fumaric acid and ammonia, or ammonium fumarate, or maleic acid and ammonia, or ammonium maleate, with immobilized cells containing aspartase or maleate isomerase.

PATENT INVENTORS This data is not available for free
PATENT ASSIGNEE This data is not available for free
PATENT FILE DATE 12.02.98
PATENT FOREIGN APPLICATION PRIORITY DATA This data is not available for free
PATENT REFERENCES CITED This data is not available for free
PATENT CLAIMS We claim:

1. An immobilized biocatalyst comprising enzyme-containing cells which are immobilized on a water-insoluble solid support by a polymer represented by the following general formula: ##STR8## wherein Y is a direct bond or a divalent group represented by the following formula ##STR9## R.sub.1 and R.sub.2 are each independently hydrogen atoms or organic residues, X.sup.- represents an anion, and n is an integer of 100-5000.

2. The immobilized biocatalyst according to claim 1, wherein said support is an ion-exchange resin or inorganic support.

3. The immobilized biocatalyst according to claim 1, wherein said support comprises granules or a sheet.

4. The immobilized biocatalyst according to claim 1, which comprises bacterial cells containing aspartase and/or maleate isomerase, or a combination of such bacterial cells.

5. The immobilized biocatalyst according to claim 2, wherein said support comprises granules or a sheet.

6. The immobilized biocatalyst according to claim 2, which comprises bacterial cells containing aspartase and/or maleate isomerase, or a combination of such bacterial cells.

7. The immobilized biocatalyst according to claim 3, which comprises bacterial cells containing aspartase and/or maleate isomerase, or a combination of such bacterial cells.

8. A process for producing L-aspartic acid or fumaric acid, comprising contacting fumaric acid and ammonia, or ammonium fumarate, or maleic acid and ammonia, or ammonium maleate, with the immobilized enzyme-containing cells according to claim 4.
PATENT DESCRIPTION BACKGROUND OF INVENTION

1. Field of Invention

The present invention relates to a novel immobilized biocatalyst and its use.

2. Related Art

Known immobilized biocatalysts include those wherein enzymes or microorganisms are bound to the surface of a solid support by physical adhesion, ion-bonding or covalent bonding, those wherein enzyme-containing substances, such as cells, are mutually crosslinked, and those wherein enzymes or enzyme-containing substances are covered in a lattice or microcapsules. A different type of immobilized catalyst is described in Japanese Unexamined Patent Publication No. 5-344898, wherein a polyazetidine prepolymer, carboxymethyl cellulose, polyurethane hydrogel prepolymer or polymethylene isocyanate is hardened on the surface of a solid support to immobilize microbial cells on the surface of the support. A disadvantage of these methods, however, is that the enzymes undergo considerable inactivation during the immobilization.

SUMMARY OF INVENTION

It is therefore an object of the present invention to provide a novel immobilized biocatalyst which overcomes this disadvantage.

As a result of much research aimed at overcoming the aforementioned disadvantage, the present inventors completed the present invention upon finding that an immobilized biocatalyst lacking that disadvantage and capable of stably maintaining its enzymatic activity for extended periods can be obtained by binding enzyme-containing cells to a solid support using a polyallylamine-based polymer which is water-soluble under acidic conditions but becomes insoluble under alkali conditions.

The present invention therefore provides an immobilized biocatalyst comprising enzyme-containing cells which are immobilized on a water-insoluble solid support by a polymer represented by the following general formula: ##STR3## wherein Y is a direct bond or a divalent group represented by the following formula ##STR4## R.sub.1 and R.sub.2 are each independently hydrogen atoms or organic residues, X.sup.- represents an anion, and n is an integer of 100 to 5000.

The present invention further provides a process for producing L-aspartic acid which is characterized by contacting fumaric acid with ammonia or ammonium fumarate, or maleic acid with ammonia or ammonium maleate on an immobilized biocatalyst which employs cells containing aspartase and/or maleate isomerase, or a combination of such cells, as the above-mentioned cells.

DETAILED DESCRIPTION

The support used for the immobilized biocatalyst of the invention may be either in granular or sheet form, with examples of granules including ion-exchange resins, for example the anionic exchange resins such as Ambalite IRA-904, IRA-94S, Ambalist A-26, A-27 (products of Organo, KK.), and the cationic exchange resins such as Ambalite 200C, 201B, IRC-50 and IRC-76 (products of Organo, KK.); and inorganic carriers such as molecular sieves, alumina, silica and silica gel. The size of the granules is preferably 0.1 mm to 10 mm, and more preferably 0.3 mm to 3 mm. As sheets there may be used ion-exchange films and alumina or silica sheets. The thickness of sheets used is preferably 0.01 mm to 10 mm, and more preferably 0.1 mm to 5 mm.

According to the invention, the resin used for immobilization of the cells is a polymer represented by the following general formula: ##STR5## wherein Y is a direct bond or a divalent group represented by the following formula ##STR6## R.sub.1 and R.sub.2 are each independently hydrogen atoms or organic residues, X.sup.- represents an anion, and n is an integer of 100 to 5000.

When R.sub.1 and R.sub.2 in the formula are organic residues, they may be alkyl groups of 10 carbon atoms or less such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl and tert-butyl, among which methyl is particularly preferred. There may also be used halogen- or hydroxyl-substituted organic residues such as 4-chloro-2-dimethylpentyl, 3-ethyl-2,5-dichloroheptyl and 2-hydroxy-3,5-dimethylnonyl, although 3-chloro-2-hydroxypropyl is particularly preferred.

X.sup.- may be a halogen ion such as F.sup.-, Cl.sup.-, Br.sup.- or I.sup.-, among which Cl.sup.- is preferred. Other monovalent anions such as NO.sub.3 -- and the like may also be used. The number represented by n is preferably 100 to 5000. Specific polymers which may be mentioned include those represented by the following structural formulas. ##STR7##

An example of a polymer of formula (A) is PAS410 (tradename), an example of a polymer of formula (B) is PAS92 (tradename), an example of a polymer of formula (C) is PAS-M-1 (tradename), an example of a polymer of formula (D) is PAS-880 and an example of a polymer of formula (E) is PAS-H-5L, all of which may be obtained from Nitto Spinning, KK. Alternatively, for example, the polymer of formula (A) may be produced by 1:1 copolymerization of a diallylamine salt (e.g. a hydrochloride) and maleic acid, the polymer of formula (B) may be produced by copolymerization or radical polymerization of a diallylamine salt (e.g. a hydrochloride) and sulfur dioxide gas, and the polymer of formula (C) may be produced by copolymerization or radical polymerization of diallylmonoalkylamines.

The cells used for the invention may be any cells containing the desired enzyme, including for example, microbial cells such as bacteria, yeast, algae and filamentous fungi, and plant cells. The enzyme is not particularly restricted, and examples of various enzymes include aspartase which converts ammonium fumarate into L-aspartic acid, maleate isomerase which converts maleic acid into fumaric acid, fumarase which converts fumaric acid into L-malic acid, malease which converts maleic acid into D-malic acid, and hydratase which converts cis-epoxy-succinic acid into L-tartaric acid. More specific examples of cells which may be used are bacterial cells containing aspartase, bacterial cells containing maleate isomerase, and bacterial cells containing both aspartase and maleate isomerase.

The following are more specific examples of microbial cells which may be used.


TABLE 1
__________________________________________________________________________
Types of reactions using immobilized biocatalysts
Starting material
Product
Enzyme
Cells
__________________________________________________________________________
Ammonium fumarate
L-aspartic acid
aspartase
Escherichia coli ATCC 11303
Escherichia coli ATCC 9637
Escherichia coli ATCC 27325
Brevibacterium
Maleic acid
fumaric acid
maleate
Pseudomonas
isomerase
Pseudomonas maltophilia ATCC 13270
Ammonium maleate
L-aspartic acid
maleate
Alcaligenes
isomerase +
Alcaligenes faecalis ATCC 8750
aspartase
Also, combinations of microbes with maleate
isomerase activity and microbes with
aspartase activity
Fumaric acid
L-malic acid
fumarase
Microbes with aspartase activity
Escherichia coli IEO 3301
Bacillus stearothermophilus DSM 2234
Sulfolobus solfataricus ATCC 49255
Maleic acid
D-malic acid
malease
Pseudomonas pseudoalcaligenes NSM-5
NSM-6
FERM P-15561
P-15562
Cis-epoxy-succinic
L-tartaric acid
hydratase
Acinetobacter tartarogenes ATCC 31105
acid
__________________________________________________________________________



When a polymer represented by the above general formula (4) is added at low concentration to a culture solution obtained by culturing one of these microbes, the cultured cells can be condensed and precipitated, thus simplifying the procedure since centrifugation of a large amount of the culture solution is unnecessary.

Specifically, the polymer represented by the above general formula (4) is added to a culture solution of the microbes to be immobilized to a solid content of 10-10,000 ppm, and preferably 100-1000 ppm, and after being allowed to stand the microbial cells aggregate and precipitate. Cooling the culture solution in advance is effective for preventing reduction of the desired enzyme activity.

After thus precipitating the microbial cells, the supernatant may be drawn out to reduce the liquid amount by a few times. For example, after 500 ppm of PAS-880 has been added to 1 L of culture solution and allowed to stand for 30 minutes, approximately 800 ml may be separated off as the supernatant. The remaining cell aggregate can then be subjected to low-speed centrifugation at 3000 rpm to recover the cells as a cake.

Because the aggregated cells can be sufficiently separated even with a low-speed centrifuge, it is possible to recover the cells with simple equipment.

The recovered cells may then be mixed with the pH-adjusted polymer either directly or after addition of water, and used as the immobilized material.

In immobilization of the cells, either one type of cell may be immobilized or two or more different types of cells may be immobilized. For example, bacterial cells containing maleate isomerase and bacterial cells containing aspartase may be immobilized in combination.

The cell immobilization may be accomplished by first mixing the cells with water and a neutral to weakly basic liquid polymer, and sprinkling it onto the solid support and drying it. The drying may be carried out using a common particle drier capable of not inactivating the enzyme in the cells, such as a rotary evaporator, fluidized bed drier or spray drier.

When the amount of immobilized cells is insufficient after a single operation, the sprinkling operation and drying operation of the polymer/cell mixture on the solid support may be repeated a number of times, for example 2 to 5 times. The proportion of the cells to be immobilized and the polymer is 4 to 200 kg, and preferably 10 to 50 kg, of polymer per 1 kg of cells (dry weight). When preparing a mixture of the polymer and cells, the amount of water added is 5 to 400 kg, and preferably 20 to 100 kg, per 1 kg of the cells. The thickness of the polymer layer containing the immobilized cells is 0.01 to 0.3 mm, and preferably 0.1 to 0.2 mm.

If the immobilized catalyst is in the form of a film, the above-mentioned cell/polymer mixture may be applied onto a sheet-like support and then dried. The density of the immobilized cells may be adjusted by varying the amount of application or the number of times the application/drying cycle is repeated.

One exemplified application for an immobilized biocatalyst of the invention is production of L-aspartic acid. In this case, an immobilized biocatalyst with immobilized aspartase-containing cells, especially bacterial cells, is packed into a column and an aqueous solution of fumaric acid and ammonia or an aqueous solution of ammonium fumarate is passed through the column.

Alternatively, an immobilized biocatalyst with immobilized cells (for example, bacterial cells) containing aspartase and maleate isomerase, or an immobilized catalyst with both immobilized cells containing aspartase and cells containing maleate isomerase on a single immobilizing support, is packed into a column and an aqueous solution of maleic acid and ammonia or an aqueous solution of ammonium maleate is passed through the column, to produce L-aspartic acid by a single-step process from maleic acid.

Still alternatively, both an immobilized biocatalyst with immobilized cells containing maleate isomerase and an immobilized catalyst with immobilized cells containing aspartase are combined and packed into a column and an aqueous solution of maleic acid and ammonia or an aqueous solution of ammonium maleate is passed through the column, to produce L-aspartic acid by a single-step process from maleic acid.

Still alternatively, an immobilized biocatalyst with immobilized cells containing maleate isomerase and an immobilized catalyst with immobilized cells containing aspartase are packed into separate columns, and an aqueous solution of maleic acid and ammonia or an aqueous solution of ammonium maleate is first passed through the immobilized biocatalyst with immobilized maleate isomerase to convert the maleic acid to fumaric acid, and is then passed through the column of the immobilized biocatalyst with immobilized aspartase to convert the ammonium fumarate to L-aspartic acid.

PATENT EXAMPLES This data is not available for free
PATENT PHOTOCOPY Available on request

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back